Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease

References

• Crohn B, Ginsburg L, Oppenheimer G. Regional ileitis: Apathological and clinical entity. JAMA 1932; 99: 1323–9
   Google Scholar
• Podolsky DK. Healing the epithelium: solving the problem from two sides. J Gastroenterol 1997; 32: 122–6
   PubMed Web of Science ®Google Scholar
• Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. Faseb J 1994; 8: 854–61
   PubMed Web of Science ®Google Scholar
• Baragi VM, Qiu L, Gunja-Smith Z, Woessner JF, Jr, Lesch CA, Guglietta A. Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcer in rats. Scand J Gastroenterol 1997; 32: 419–26
   PubMed Web of Science ®Google Scholar
• Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut 1995; 37: 805–10
   PubMed Web of Science ®Google Scholar
• Matthes H, Herbst H, Schuppan D, Stallmach A, Milani S, Stein H, et al. Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology 1992; 102: 431–42
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol 1994; 47: 113–6
   PubMed Web of Science ®Google Scholar
• Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg ML. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 1996; 148: 519–26
   PubMed Web of Science ®Google Scholar
• von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000; 47: 63–73
   PubMed Web of Science ®Google Scholar
• Baugh MD, Perry MJ, Hollander AP, Davies DR, Cross SS, Lobo AJ, et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999; 117: 814–22
   PubMed Web of Science ®Google Scholar
• Stallmach A, Chan CC, Ecker KW, Feifel G, Herbst H, Schuppan D, et al. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 2000; 47: 415–22
   PubMed Web of Science ®Google Scholar
• Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, et al. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000; 120: 241–6
   PubMed Web of Science ®Google Scholar
• Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269: 16766–73
   PubMed Web of Science ®Google Scholar
• Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR, et al. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 2001; 61: 7091–100
   PubMed Web of Science ®Google Scholar
• Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996; 97: 761–8
   PubMed Web of Science ®Google Scholar
• Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996; 97: 2011–9
   PubMed Web of Science ®Google Scholar
• Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997; 40: 1391–9
   PubMed Web of Science ®Google Scholar
• Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99: 2503–9
   PubMed Web of Science ®Google Scholar
• Mao D, Lee JK, VanVickle SJ, Thompson RW. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem Biophys Res Commun 1999; 261: 904–10
   PubMed Web of Science ®Google Scholar
• Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. Embo J 1999; 18: 4645–56
   PubMed Web of Science ®Google Scholar
• Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, et al. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 1998; 152: 1489–99
   PubMed Web of Science ®Google Scholar
• Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998; 152: 1005–14
   PubMed Web of Science ®Google Scholar
• Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997; 272: 7608–16
   PubMed Web of Science ®Google Scholar
• Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity in ulcerative colitis: what does it mean?. Gut 1991; 32: 174–8
   PubMed Web of Science ®Google Scholar
• Ashworth JL, Murphy G, Rock MJ, Sherratt MJ, Shapiro SD, Shuttleworth CA, et al. Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J 1999; 340: 171–81
   PubMed Web of Science ®Google Scholar
• Uria JA, Stahle-Backdahl M, Seiki M, Fueyo A, Lopez-Otin C. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal–epithelial cell interactions. Cancer Res 1997; 57: 4882–8
   PubMed Web of Science ®Google Scholar
• Cowell S, Knauper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, et al. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998; 331: 453–8
   PubMed Web of Science ®Google Scholar
• Strobach RS, Ross AH, Markin RS, Zetterman RK, Linder J. Neural patterns in inflammatory bowel disease: an immunohistochemical survey. Mod Pathol 1990; 3: 488–93
   PubMed Web of Science ®Google Scholar
• Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544–50
   PubMed Web of Science ®Google Scholar
• Di Sebastiano P, di Mola FF, Artese L, Rossi C, Mascetta G, Pernthaler H, et al. Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis. Digestion 2001; 63: 234–9
   PubMed Web of Science ®Google Scholar